Aardvark Therapeutics Inc (AARD) PT Raised to $26 at BofA Securities

March 27, 2025 5:18 AM EDT Send to a Friend
BofA Securities analyst Tim Anderson raised the price target on Aardvark Therapeutics Inc (NASDAQ: AARD) to $26.00 (from $22.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login